Jun 23, 2025, 08:09 AM by

Alithea Genomics has announced the launch of MERCURIUS™ Total DRUG-seq to push the boundaries of high-throughput drug screens, toxicology screens and target validation.

Jun 23, 2025, 08:09 AM by

As supply chain instability and international backorders continue to affect the life sciences and diagnostics sectors, Zymo Research is stepping in with scalable, U.S.-based alternatives. Our latest announcement spotlights our domestic manufacturing capabilities and our role as a long-standing OEM and development partner, helping research and clinical labs maintain continuity without compromise. We believe this is especially relevant to your readers, many of whom are actively seeking reliable domestic partners. We invite you to read the full press release here: https://www.zymoresearch.com/blogs/press-releases/supply-chain-challenges

Jun 23, 2025, 08:09 AM by

Jun 23, 2025, 08:09 AM by

Bill Kerr of Avalon Healthcare Solutions Named EY Entrepreneur Of The Year® 2025 Florida Award Winner - Leader in Diagnostic Intelligence & Insights Earns Top Recognition for Transformative Work

Jun 23, 2025, 08:07 AM by

Lindus Health Named a Fierce CRO Award Winner in the Outstanding Patient Recruitment and Retention Category

Jun 23, 2025, 08:07 AM by

Jun 19, 2025, 01:00 AM by User Not Found

Bio-IT World | Nanoneedle technology developed by researchers from King’s College London offers the ability to extract molecular information from living tissue without damaging or killing cells—offering spatial and longitudinal molecular insights that is described as a “fundamental scientific breakthrough.”

Jun 18, 2025, 08:31 AM by

• Platform is built on biologically labelled, organ-specific multi-omics data carried by extracellular vesicles isolated from 2ml plasma samples • Enables differentiated AI-powered biomarker discovery and IVD translation for patient stratification, therapeutic monitoring, surrogate markers and other diagnostic development programs • Publication of pre-print data, with support from Evotec International GmbH and University College London demonstrates validation of Platform’s capability for liver diseases

Jun 18, 2025, 08:31 AM by

Qureight, a deep-learning analytics company accelerating drug development through AI-powered data curation, today announced that its digitally-twinned synthetic control arm has been used in a breakthrough clinical trial application in place of a human placebo group, marking a world-first in lung disease research. The study, presented at the American Thoracic Society, demonstrates significant clinical efficacy for Avalyn’s inhaled pirfenidone (AP01), a promising treatment for idiopathic pulmonary fibrosis (IPF), a rare and high-mortality lung disease.

Jun 18, 2025, 08:31 AM by

One2Treat SA, a fast-growing tech company incorporating the patient voice in all strategic decisions about treatment assessments in Pharma R&D, today announced the launch of the One2Treat Voice app, a new module of their software platform.

Jun 18, 2025, 08:31 AM by

Jun 18, 2025, 08:31 AM by

MIB Agents, a leading pediatric osteosarcoma nonprofit, announced it has awarded $2.5 million in research grants through its OutSmarting Osteosarcoma program, which is powered by families honoring children affected by the disease. At its upcoming FACTOR Conference (June 26–28) in Salt Lake City, the organization will award $700,000 in grants to 10 scientists advancing less toxic, more effective treatments. The grants, which include four $100,000 Hero Grants and six $50,000 Hope Young Investigator Grants, reflect a unique collaboration between researchers and the osteosarcoma community, with families actively funding and participating in the review of scientific proposals.

Jun 18, 2025, 08:31 AM by

Jun 18, 2025, 08:31 AM by

Jun 18, 2025, 08:31 AM by

The new platform is designed to break down barriers to early-phase trial access, bringing "Hope Through Access" to communities and patients who need it most.

Jun 18, 2025, 01:00 AM by User Not Found

Bio-IT World | The International Myeloma Foundation's ambitious Black Swan Research Initiative is orchestrating a global collaborative effort to achieve what has long eluded researchers: a true cure for multiple myeloma. Through research partnerships spanning five continents, the initiative is systematically testing multiple therapeutic approaches while revolutionizing how cancer drug approvals are evaluated.

Jun 17, 2025, 08:19 AM by

Insilico Medicine(“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced the close of its Series E financing round at a total of around $123 million, surpassing its initial target amid strong investor interest.

Jun 17, 2025, 08:19 AM by

ClearNote Health announced initiation of patient enrollment for a new study that aims to advance early detection of pancreatic cancer in individuals newly diagnosed with type 2 diabetes.

Jun 17, 2025, 08:19 AM by

Key appointment to lead the company’s financial strategy and support continued global growth in sample stability and biorepository storage solutions

Jun 17, 2025, 01:00 AM by User Not Found

Bio-IT World | Findable, Accessible, Interoperable and Reusable (FAIR) principles continue to hold an important place in data management and access, artificial intelligence (AI) and machine learning (ML) development, and data sharing between organizations. But FAIR is also complex to implement due to the original FAIR guidelines not being explicit and difficult to understand or visualize for non-experts. The FAIR community of experts with the Pistoia Alliance developed a self-assessment tool that can measure an organization’s FAIR maturity level.